About Us | Company Profile

As we explore new frontiers of medicine, we are inspired each day to push the limits of research and development in order to discover innovative methods of treating disease. Our mission: to develop the next generation of biomedicines by harnessing the therapeutic potential of the human cell.

Founded by Hubert JP Schoemaker, one of biotechnology’s earliest pioneers, Neuronyx is developing a cellular therapy with the potential to significantly improve upon the treatment of numerous diseases. This therapy is designed to supplement and stimulate the body’s natural repair mechanism when it is overwhelmed by illness or injury. By promoting the repair and regeneration of damaged tissue, Neuronyx’ investigational treatment may also have the potential to reverse the course of disease, unlike existing therapies which may only slow or halt its progression.

Neuronyx’ cell therapy, produced by its proprietary expansion process, allows the manufacture of billions of doses from just one human adult bone marrow donor, ensuring product consistency and effectively eliminating commercial challenges associated with the production of a cellular therapy.